Immediate Impact
3 from Science/Nature 50 standout
Citing Papers
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of Sofia Dória being referenced
AT-11 * FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM
2014
Randomized Phase Ii Trial Avareg (Ml25739) with Bevacizumab (Bev) or Fotemustine (Ftm) in Recurrent Gbm: Final Results from the Randomized Phase Ii Trial
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sofia Dória | 202 | 240 | 190 | 49 | 524 | |
| Noémie Ranisavljevic | 134 | 330 | 76 | 34 | 541 | |
| Yibo Wu | 99 | 219 | 71 | 50 | 507 | |
| Michael Volodarsky | 136 | 204 | 56 | 30 | 523 | |
| Alida C. Knegt | 221 | 262 | 209 | 34 | 591 | |
| Avinash Thakur | 72 | 266 | 69 | 38 | 543 | |
| Hongguo Zhang | 285 | 260 | 195 | 99 | 631 | |
| Moez Gribaa | 264 | 335 | 154 | 51 | 645 | |
| Sateesh Maddirevula | 200 | 340 | 67 | 36 | 625 | |
| Lu Luo | 85 | 221 | 100 | 35 | 519 | |
| Zhiying Su | 302 | 243 | 78 | 40 | 635 |
All Works
Login with ORCID to disown or claim papers
Loading papers...